Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its ...

The partnership strengthens INBS' global manufacturing strategy, reducing reliance on a single supplier and building greater resilience into its supply chain. It further broadens capacity, ensures ...

INBS surged on strategic manufacturing partnership and revenue growth, but pulled back after announcing plans to raise $10 ...

Intelligent Bio Solutions Inc. (INBS) shares soared 20% in Wednesday’s pre-market trade after the company announced a new ...

NEW YORK – Captured Venezuelan President Nicolás Maduro pleaded not guilty in a Manhattan federal court Jan. 5 to charges that he led a conspiracy to transport thousands of tons of cocaine into the ...

The collaboration will enable Intelligent Bio Solutions to scale production of its breakthrough drug-screening device to meet ...

The reverse stock split was approved by Intelligent Bio Solutions' stockholders at the annual meeting of the Company's stockholders held on October 16, 2025, with the final ratio to be determined by ...

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...

NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...

NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”) a medical technology company delivering intelligent, rapid, non-invasive testing solutions, ...